Interview with Patrick Garrahy, Managing Director, Rottapharm Ireland
Mr. Garrahy, can you please begin by introducing yourself and this production facility to our readers? I joined…
Rottapharm Ireland
Last updated: 13.02.2014
Address: Damastown Industrial Park Mulhuddart, Dublin.,Ireland
Tel: +353-1-8852700
Web: http://www.rotta.com/en/index.html
Company description
Rottapharm established their Irish manufacturing facility in 1999. Construction of the facility commenced in 1998 on a 20 acre site in Mulhuddart, West Dublin. The facility was completed in July 1999 and obtained a manufacturing licence from the Irish Medicines Board in January 2000.
Products and services
The main product manufactured in Mullhuddart is DONA for which the active ingredient is Glucosamine Sulphate. Both the active ingredient and the finished product in the form of capsules and sachets are manufactured in Mulhuddart. The company also manufactures Bromelain tablets (ANANASE), an anti-inflammatory agent derived from the pineapple tree and a sustained release formulation of Aspirin (TROMALYT).
Employment in the company currently stands at 150 people. The facility has a footprint of 10,000 sq. metres. Product manufactured on site is shipped to over 60 contries.
Interviews
Related
Ireland / Abbott Splashes the Cash on New R&D Investment; Bausch & Lomb Ramps Up Manufacturing Footprint; Looming Pricing Crisis
The latest news from Irish pharma, including a big new R&D investment for Abbott; contact lens giant Bausch…
Interview: Eoin Vaughan – CEO; Dermot Gildea – Director of Life…
Eoin Vaughan, CEO of Mercury Engineering, and Dermot Gildea, Director of Life Sciences, highlight the key…
Interview: David Adlam – Regional Manager, Ireland and South West UK; Paul…
David Adlam, Regional Manager of Ireland and South West UK, and Paul Morris, Strategic Account Manager for Life…
Interview: Jean Delaney – Pharma Leader, Partner, PwC Ireland
Jean Delaney, pharma leader and partner at PwC Ireland, discusses the evolution she has seen in the pharma market,…
Ipsen: A Track Record of Excellence in Ireland
These are exciting times for Ipsen in Ireland, with plans to expand the company’s already significant API…
Brexit and Irish Pharma
The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring…
Interview: Philip Hendrick – Managing Director, Air Liquide Healthcare…
Philip Hendrick, the Managing Director of Air Liquide Healthcare Ireland, a provider of home-based respiratory…
Cora Systems’ Innovative Project Management Solutions
Philip Martin, founder and CEO of Cora Systems in Ireland, explains why his company is ideally positioned to help…
Interview: Brendan McAtamney – CEO, UDG Healthcare, Ireland
Brendan McAtamney, CEO of UDG Healthcare, details the company’s impressive growth in recent years, particularly…
Interview: Tom Coogan – General Manager, Grünenthal Ireland
Grünenthal Ireland’s General Manager discusses the incredible growth of the Irish affiliate over the past twelve…
Putting the ‘R’ & ‘D’ back into Ireland
Much like the Irish sport of hurling, conducting R&D in Ireland is something often overlooked – unfairly, as…
Interview: Sorcha McKenna – Partner, McKinsey & Company Ireland
Sorcha McKenna, Partner at McKinsey & Company in Ireland, discusses the current trends in the Irish healthcare…
